| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |